Cresco Labs and Columbia Care are two of the top ten cannabis businesses in North America. The purchase of Columbia Care by its long-standing rival for over $2 billion will be one of the biggest deals in the budding legal global cannabis space. This business deal will merge two fundamental operators in the cannabis sector and create a new leader with the best of both companies. Columbia Care, with its leading footprints, and Cresco Labs, its on-brand and competitive excellence. This merge will be the envy of other top shots in space.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…